Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ · Healthcare
Aurinia Pharmaceuticals Inc. Gross Profit 2018–2025
Aurinia Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Aurinia Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 71.2 M, a 32.12% increase year-over-year.
- Aurinia Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 253.3 M, a 26.44% increase year-over-year.
- Aurinia Pharmaceuticals Inc. annual gross profit for 2025 was 250.4 M, a 21.03% increase from 2024.
- Aurinia Pharmaceuticals Inc. annual gross profit for 2024 was 206.9 M, a 28.21% increase from 2023.
- Aurinia Pharmaceuticals Inc. annual gross profit for 2023 was 161.4 M, a 25.71% increase from 2022.
- Aurinia Pharmaceuticals Inc. annual gross profit for 2022 was 128.4 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aurinia Pharmaceuticals Inc. Gross Profit — FAQ
Aurinia Pharmaceuticals Inc. (AUPH) gross profit over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Aurinia Pharmaceuticals Inc.'s gross profit?
Aurinia Pharmaceuticals Inc. (AUPH) reported gross profit of $250M for fiscal 2025.
Where can I see AUPH's gross profit history?
The chart and table above show Aurinia Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.